ADMA BIOLOGICS INC (ADMA)
US0008991046 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 80.9M 91.71% | 154.1M 90.48% | 258.215M 67.56% | 430.8M 66.84% | 494.22M 14.72% | 635.66M 28.62% | 740.72M 16.53% | 941.61M 27.12% | 1.033B 9.71% | 1.11B 7.45% | 1.134B 2.16% | |
| EBITDA YoY % growth | -52.9M 13.22% | -32.19M 39.15% | 32.064M 199.61% | 169.35M 428.16% | 230.09M 35.87% | 284.27M 23.55% | 347.16M 22.12% | 470.32M 35.48% | 563.65M 19.84% | 648.72M 15.09% | N/A | |
| EBIT YoY % growth | -58.4M 10.02% | -39.3M 32.71% | 23.732M 160.39% | 146.41M 516.93% | 202.94M 38.61% | 287.61M 41.72% | 350.34M 21.81% | 461.04M 31.60% | 516.58M 12.05% | 563.5M 9.08% | 568.75M 0.93% | |
| Operating Margin | -72.19% | -25.50% | 9.19% | 33.99% | 41.06% | 45.25% | 47.30% | 48.96% | 50.01% | 50.77% | 50.15% | |
| EPS YoY % growth | -0.52 39.53% | -0.31 40.38% | -0.13 58.06% | 0.52 502.12% | 0.74 41.95% | 1.00 34.71% | 1.18 18.03% | 1.50 27.09% | 1.69 12.93% | 1.86 9.64% | 1.84 -1.10% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.16 297.63% | 0.16 100.81% | 0.17 33.38% | 0.19 27.50% | 0.21 32.26% |
| Revenue Q2Q % growth | 115.67M 56.51% | 115.16M 40.65% | 119.55M 11.53% | 127.63M 6.50% | 131.84M 13.98% |
| EBITDA Q2Q % growth | 50.645M 124.44% | 51.749M 116.21% | 56.664M 30.68% | 59.825M 30.80% | 61.856M 22.14% |
| EBIT Q2Q % growth | 43.735M 207.27% | 44.857M 105.57% | 48.518M 23.77% | 52.996M 33.70% | 56.541M 29.28% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.15 1,400.00% | 0.13 | 0.02 | 13.12% |
| Q2 2024 Q2Q % growth | 0.13 533.33% | 0.08 | 0.05 | 59.31% |
| Q1 2024 Q2Q % growth | 0.08 366.67% | 0.06 | 0.02 | 42.60% |
| Q4 2023 Q2Q % growth | -0.08 -33.33% | 0.03 | -0.11 | -413.73% |
| Q3 2023 Q2Q % growth | 0.01 112.50% | -0.01 | 0.02 | 230.72% |
| Q2 2023 Q2Q % growth | -0.03 57.14% | -0.03 | 0.00 | -17.65% |
| Q1 2023 Q2Q % growth | -0.03 70.00% | -0.04 | 0.01 | 30.80% |
| Q4 2022 Q2Q % growth | -0.06 33.33% | -0.06 | 0.00 | 5.88% |
| Q3 2022 Q2Q % growth | -0.08 38.46% | -0.08 | 0.00 | -1.20% |
| Q2 2022 Q2Q % growth | -0.07 50.00% | -0.08 | 0.01 | 14.22% |
| Q1 2022 Q2Q % growth | -0.10 37.50% | -0.09 | -0.01 | -15.34% |
| Q4 2021 Q2Q % growth | -0.09 55.00% | -0.10 | 0.01 | 5.46% |
| Q3 2021 Q2Q % growth | -0.13 31.58% | -0.15 | 0.02 | 11.49% |
| Q2 2021 Q2Q % growth | -0.14 39.13% | -0.15 | 0.01 | 8.50% |
| Q1 2021 Q2Q % growth | -0.16 33.33% | -0.17 | 0.01 | 5.50% |
| Q4 2020 Q2Q % growth | -0.20 -11.11% | -0.16 | -0.04 | -21.66% |
| Q3 2020 Q2Q % growth | -0.19 | -0.19 | 0.00 | 0.21% |
| Q2 2020 Q2Q % growth | -0.23 8.00% | -0.16 | -0.07 | -43.62% |
| Q1 2020 Q2Q % growth | -0.24 25.00% | -0.13 | -0.11 | -90.52% |
| Q4 2019 Q2Q % growth | -0.18 53.85% | -0.18 | 0.00 | -1.49% |
| Q3 2019 Q2Q % growth | -0.19 42.42% | -0.23 | 0.04 | 17.84% |
| Q2 2019 Q2Q % growth | -0.25 26.47% | -0.29 | 0.04 | 14.64% |
| Q1 2019 Q2Q % growth | -0.32 17.95% | -0.32 | 0.00 | 0.72% |
| Q4 2018 Q2Q % growth | -0.39 | -0.35 | -0.04 | -10.14% |
| Q3 2018 Q2Q % growth | -0.33 | -0.32 | -0.01 | -4.36% |
| Q2 2018 Q2Q % growth | -0.34 | -0.32 | -0.02 | -6.38% |
| Q1 2018 Q2Q % growth | -0.39 | -0.31 | -0.08 | -24.34% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 119.839M 78.13% | 107.97M | 11.869M | 10.99% |
| Q2 2024 Q2Q % growth | 107.191M 78.29% | 88.141M | 19.05M | 21.61% |
| Q1 2024 Q2Q % growth | 81.875M 43.86% | 78.821M | 3.054M | 3.87% |
| Q4 2023 Q2Q % growth | 73.904M 47.87% | 73.593M | 310.68K | 0.42% |
| Q3 2023 Q2Q % growth | 67.275M 63.72% | 63.368M | 3.907M | 6.16% |
| Q2 2023 Q2Q % growth | 60.123M 77.30% | 56.61M | 3.513M | 6.21% |
| Q1 2023 Q2Q % growth | 56.914M 95.58% | 54.477M | 2.437M | 4.47% |
| Q4 2022 Q2Q % growth | 49.98M 89.46% | 46.848M | 3.132M | 6.69% |
| Q3 2022 Q2Q % growth | 41.09M 98.69% | 35.174M | 5.916M | 16.82% |
| Q2 2022 Q2Q % growth | 33.91M 90.19% | 32.448M | 1.462M | 4.51% |
| Q1 2022 Q2Q % growth | 29.1M 81.31% | 28.713M | 387K | 1.35% |
| Q4 2021 Q2Q % growth | 26.38M 88.97% | 22.193M | 4.187M | 18.87% |
| Q3 2021 Q2Q % growth | 20.68M 101.17% | 19.1M | 1.58M | 8.27% |
| Q2 2021 Q2Q % growth | 17.83M 128.88% | 16.744M | 1.086M | 6.49% |
| Q1 2021 Q2Q % growth | 16.05M 57.35% | 14.87M | 1.18M | 7.94% |
| Q4 2020 Q2Q % growth | 13.96M 15.95% | 13.167M | 793K | 6.02% |
| Q3 2020 Q2Q % growth | 10.28M 42.38% | 10.159M | 121K | 1.19% |
| Q2 2020 Q2Q % growth | 7.79M 18.75% | 10.784M | -2.994M | -27.76% |
| Q1 2020 Q2Q % growth | 10.2M 188.95% | 11.093M | -893K | -8.05% |
| Q4 2019 Q2Q % growth | 12.04M 196.55% | 10.599M | 1.441M | 13.60% |
| Q3 2019 Q2Q % growth | 7.22M 70.69% | 5.653M | 1.567M | 27.72% |
| Q2 2019 Q2Q % growth | 6.56M 40.77% | 3.409M | 3.151M | 92.43% |
| Q1 2019 Q2Q % growth | 3.53M -12.62% | 3.28M | 250K | 7.62% |
| Q4 2018 Q2Q % growth | 4.06M | 5.051M | -991K | -19.62% |
| Q3 2018 Q2Q % growth | 4.23M | 4.782M | -552K | -11.54% |
| Q2 2018 Q2Q % growth | 4.66M | 5.606M | -946K | -16.87% |
| Q1 2018 Q2Q % growth | 4.04M | 6.314M | -2.274M | -36.02% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 47.62% | 6.33% | 4.59% |
| Revenue | 0% | 16.25% | 4.01% | 4.09% |